At a glance
ClinicalIndex Comparison RecordN/ACompleted· 17 enrolled
Drug / intervention
Magteindietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Use of Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Mild to Moderate Dementia
In Brief
A clinical study evaluating Magtein for Dementia and Alzheimer's Disease. Completed, enrolled 17 participants across 1 site.
Detailed Summary
The purpose of this study is to examine the effects of supplementing Magnesium L-Threonate in people with mild to moderate dementia. The investigators' goal is to understand whether Magnesium L-Threonate will be associated with improvement in memory and brain function.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDementia, Alzheimer's Disease
CountriesUnited States
CollaboratorsMagceutics, Inc.
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJul 2014
First PostedAug 2014
Primary CompletionApr 2016
Study CompletionJul 2016
TodayJul 2026
First PostedAug 6, 2014
Enrollment StartJul 1, 2014
Primary CompletionApr 1, 2016
Study CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.9 years ago
Interventions
Magteindietary